• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Gut microbiota: a novel target and new perspective for the prevention and treatment of kidney stones.

作者信息

Chen Songhe, Zhang Ying

机构信息

Gulou Subdistrict Community Health Center, Haishu District, Ningbo, 315000, Zhejiang, China.

Ningbo Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, No. 819, Liyuan North Road, Ningbo, 315000, Zhejiang, China.

出版信息

Urolithiasis. 2025 Aug 19;53(1):159. doi: 10.1007/s00240-025-01835-9.

DOI:10.1007/s00240-025-01835-9
PMID:40828253
Abstract
摘要

相似文献

1
Gut microbiota: a novel target and new perspective for the prevention and treatment of kidney stones.肠道微生物群：预防和治疗肾结石的新靶点与新视角
Urolithiasis. 2025 Aug 19;53(1):159. doi: 10.1007/s00240-025-01835-9.
2
Gut microbiota-derived indole-3-acetic acid ameliorates calcium oxalate renal stone formation via AHR/NF‑κB axis.肠道微生物群衍生的吲哚-3-乙酸通过芳烃受体/核因子κB轴改善草酸钙肾结石的形成。
Urolithiasis. 2025 Jul 2;53(1):134. doi: 10.1007/s00240-025-01779-0.
3
Human fecal microbiota transplantation attenuates high dietary oxalate-induced renal calcium oxalate crystal depositions in rats via repairing related gut barrier damage.人粪便微生物群移植通过修复相关肠道屏障损伤减轻高膳食草酸盐诱导的大鼠肾草酸钙晶体沉积。
mSystems. 2025 Aug 25:e0081025. doi: 10.1128/msystems.00810-25.
4
Citrate salts for preventing and treating calcium containing kidney stones in adults.用于预防和治疗成人含钙肾结石的柠檬酸盐。
Cochrane Database Syst Rev. 2015 Oct 6;2015(10):CD010057. doi: 10.1002/14651858.CD010057.pub2.
5
Kidney-Gut Axis in Chronic Kidney Disease: Therapeutic Perspectives from Microbiota Modulation and Nutrition.慢性肾脏病中的肾-肠轴：微生物群调节与营养的治疗前景
Nutrients. 2025 Jun 9;17(12):1961. doi: 10.3390/nu17121961.
6
Integrated oral-gut microbiota therapy: a novel perspective on preventing bacterial translocation for systemic disease management.口腔-肠道微生物群综合疗法：预防细菌易位以管理全身性疾病的新视角。
Front Cell Infect Microbiol. 2025 Jul 28;15:1641816. doi: 10.3389/fcimb.2025.1641816. eCollection 2025.
7
Prediction of calcium oxalate kidney stones: A comprehensive analysis of clinical and gut microbiome characteristics.草酸钙肾结石的预测：临床和肠道微生物群特征的综合分析
Medicine (Baltimore). 2025 Jul 18;104(29):e43103. doi: 10.1097/MD.0000000000043103.
8
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理（2025年结石病专家共识）
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
9
The effects of Shenkang suppository on kidney function and gut microbiota in nondialysis patients with chronic kidney disease stages 3-4: A randomized controlled trial.肾康栓对3-4期非透析慢性肾脏病患者肾功能及肠道微生物群的影响：一项随机对照试验
Front Pharmacol. 2025 Jul 29;16:1621208. doi: 10.3389/fphar.2025.1621208. eCollection 2025.
10
Indapamide or chlorthalidone to reduce urine supersaturation for secondary prevention of kidney stones: protocol for a randomised, double-blind, cross-over trial (INDAPACHLOR).吲达帕胺或氯噻酮降低尿过饱和度用于肾结石二级预防：一项随机、双盲、交叉试验（INDAPACHLOR）的方案
BMJ Open. 2025 Jun 16;15(6):e101594. doi: 10.1136/bmjopen-2025-101594.

本文引用的文献

1
Gut Microbiota-Derived butyric acid attenuates kidney stone formation in humans and mice.肠道微生物群产生的丁酸可减轻人类和小鼠的肾结石形成。
Urolithiasis. 2025 Jul 28;53(1):146. doi: 10.1007/s00240-025-01812-2.
2
Gut microbiota and the prevalence and incidence of renal stones.肠道微生物群与肾结石的患病率和发病率。
Sci Rep. 2022 Mar 8;12(1):3732. doi: 10.1038/s41598-022-07796-y.